Certain A Shares of GuiZhou SanLi Pharmaceutical Co.,LTD. are subject to a Lock-Up Agreement Ending on 28-APR-2023.
April 27, 2023
Share
Certain A Shares of GuiZhou SanLi Pharmaceutical Co.,LTD. are subject to a Lock-Up Agreement Ending on 28-APR-2023. These A Shares will be under lockup for 1101 days starting from 22-APR-2020 to 28-APR-2023.
Details:
The company holding stockholder, actual controller Zhang Hai committed that within 36 months from the listing date of the company's shares, will not transfer nor entrust to a third party shares directly or indirectly held in the company, nor allow the company to repurchase the said shares.
Close relatives of company holding stockholder, actual controller Zhang Hai who hold shares in the company, namely, Wang Huiying, Ling Zongrong committed that within 36 months from the listing date of the company's shares, will not transfer nor entrust to a third party shares directly or indirectly held in the company, nor allow the company to repurchase the said shares.
Guizhou Sanli Investment Partnership Enterprise (Limited Partnership) who holds shares in the company committed: within 36 months from the listing date of the company's shares, will not transfer nor entrust to a third party shares directly or indirectly held in the company, nor allow the company to repurchase the said shares.
The Company director, senior management personnel Sheng Yongjian, Zhang Qianfan, Zhang Hongyu, Fan Xiaobo, Xie Zhen, Wang Yi, committed that within 36 months from the listing date of the company's shares, will not transfer nor entrust to a third party shares directly or indirectly held in the company, nor allow the company to repurchase the said shares.
Guizhou Sanli Pharmaceutical Co Ltd is a company mainly engaged in the research and development, production and sales of Chinese patent medicines. The Company's product lines cover various areas, including pediatrics, respiratory systems, cardio-cerebrovascular and gastroenterology. Its main products are Kaihoujian spray (Pediatric Use), Kaihoujian spray and Qiangli Gastrodia Elata Eucommia capsules. The Kaihoujian spray (Pediatric Use) and Kaihoujian spray are used for the treatment of respiratory and oral diseases, and the Qiangli Gastrodia Elata Eucommia capsule is used for the treatment of cardiovascular and cerebrovascular diseases. The Company mainly sells its products through specialized academic marketing.